ImageneBio IMA Cash Flow Statement (2020-2025)

NASDAQ IMA
$4.95 -0.06 (-1.20%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

ImageneBio Quarterly Cash Flow Statement

Periods 23 quarters
Latest Sep 2025

ImageneBio reported cash from operations of -$21.50M and free cash flow of -$21.50M for the quarter ended Sep 2025, down 265.8% year over year. This cash flow statement covers 23 quarters of results from Mar 2020 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income
-26.05M-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-7.60M-24.75M
Share-based CompensationStock Comp.
0.65M4.93M5.10M5.51M1.58M6.27M6.58M6.70M1.86M7.65M7.56M7.42M1.75M8.70M8.25M8.16M5.29M6.54M6.33M7.50M
Asset Writedowns and ImpairmentWritedown
0.74M
Cash from OperationsCash from Ops.
-12.57M-13.17M-15.72M-17.99M-13.37M-19.78M-19.45M-17.22M-17.66M-19.78M-18.14M-20.00M-21.82M-18.30M-12.50M12.96M-28.16M-7.23M-11.90M-21.50M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.53M0.60M0.58M0.31M0.39M0.42M-0.50M1.16M0.08M0.08M0.31M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M
Change in Working Capital
Change in Account PayablesChange Payables
0.43M0.05M0.40M-0.55M0.46M0.00M0.95M-1.16M-0.09M0.67M-0.99M-0.67M-1.88M-0.16M-0.50M-1.58M1.07M1.43M-0.46M-3.14M
Change in Accured ExpensesChange Accured Exp.
1.32M-1.81M0.94M0.47M1.70M-1.52M0.83M3.51M-0.59M-2.92M0.91M-3.30M-2.35M-3.76M-1.72M4.76M-1.75M-0.31M0.29M-9.93M
Other Working Capital ChangesOther WC Changes
-0.07M-3.47M-3.55M-3.75M-20.22M-3.38M-0.38M-6.40M-5.45M-5.31M-2.00M-1.19M-0.66M-0.65M
Investing Activities
Capital ExpendituresCapex
0.64M0.84M0.19M0.18M0.55M0.03M0.91M0.26M0.23M0.15M0.26M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.06M0.18M0.62M-0.43M
Change in Acquisitions & DivestmentsChange Acquisitions
51.78M37.20M31.07M28.00M50.06M45.48M13.50M13.70M-17.05M50.31M2.25M
Cash from Investing ActivitiesCash from Investing
3.04M-0.84M-0.19M-0.18M-0.55M-166.05M20.49M35.78M10.50M-10.81M22.68M31.89M20.38M-48.74M3.92M55.84M-45.92M-4.45M
Financing Activities
Other financing activitiesOther financing
0.05M132.43M-1.13M0.49M0.57M0.02M0.00M0.01M0.04M
Cash from Financing ActivitiesCash from Financing
116.16M132.53M-1.09M0.07M0.24M0.49M0.57M0.02M0.00M38.92M0.06M0.03M13.02M122.42M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.37M3.44M0.88M1.93M1.37M1.75M1.83M2.38M1.14M
Net Equity Issued and RepurchasedNet Equity Issued
-0.12M
Additional items
Exchange Rate EffectFX Effect
0.00M-0.01M0.66M
Change in Cash
106.63M118.52M-17.01M-18.11M-13.68M-185.34M1.61M18.59M-7.16M-30.59M41.54M50.81M-1.38M-67.04M-8.58M68.92M-74.20M-7.20M1.10M97.14M
Free Cash FlowFCF
-13.21M-14.01M-15.91M-18.17M-13.92M-19.82M-20.36M-17.48M-17.89M-19.94M-18.14M-20.00M-22.08M-18.30M-12.50M12.96M-28.16M-7.23M-11.90M-21.50M
Net Cash FlowNCF
106.63M118.52M-17.01M-18.11M-13.68M-185.34M1.61M18.59M-7.16M-30.59M4.54M50.81M-1.38M-67.04M-8.58M68.80M-74.08M-7.20M1.12M96.48M